Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (UK)

Index « Auteurs » - entrée « Robert S. Mckelvie »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Robert S. Kauffman < Robert S. Mckelvie < Robert S. Onsare  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000217 (2017) Parul U. Gandhi [États-Unis] ; Sheryl L. Chow [États-Unis] ; Thomas S. Rector [États-Unis] ; Henry Krum [Australie] ; Hanna K. Gaggin [États-Unis] ; John J. Mcmurray [Royaume-Uni] ; Michael R. Zile [États-Unis] ; Michel Komajda [France] ; Robert S. Mckelvie [Canada] ; Peter E. Carson [États-Unis] ; James L. Januzzi [États-Unis] ; Inder S. Anand [États-Unis]Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
003203 (2005) John Mcmurray [Royaume-Uni] ; Alain Cohen-Solal [France] ; Rainer Dietz [Allemagne] ; Eric Eichhorn [États-Unis] ; Leif Erhardt [Suède] ; F. D. Richard Hobbs [Royaume-Uni] ; Henry Krum [Australie] ; Aldo Maggioni [Italie] ; Robert S. Mckelvie [Canada] ; Ileana L. Pi A [États-Unis] ; Jordi Soler-Soler [Espagne] ; Karl Swedberg [Suède]Practical recommendations for the use of ACE inhibitors, beta‐blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice

List of associated KwdEn.i

Nombre de
documents
Descripteur
1Aetiology
1Aged
1Aldosterone
1Aldosterone antagonist
1Aldosterone antagonists
1Angiotensin
1Angiotensin II Type 1 Receptor Blockers (therapeutic use)
1Angiotensin receptor blockers
1Angiotensinconverting enzyme inhibitors
1Antagonist
1Arb
1Arch intern
1Asymptomatic
1Beta
1Beta blocker
1Beta blockers
1Biochemical monitoring
1Biphenyl Compounds (therapeutic use)
1Blocker
1Blood chemistry
1Blood pressure
1Calcium channel blockers
1Candesartan
1Cardiol
1Cardiology
1Carvedilol
1Cause of Death (trends)
1Check blood chemistry
1Chronic heart failure
1Clinical practice
1Clinical recommendations
1Clinical trials
1Coll cardiol
1Combination preparations
1Congestive
1Congestive heart failure
1Creatinine
1Daily target dose
1Digoxin
1Diuretic
1Diuretic dose
1Diuretics amiloride
1Dos
1Dose
1Dose advice
1Double dose
1Drug interactions
1Dysfunction
1Elderly patients
1Engl
1Enzyme inhibitors
1Eplerenone
1European journal
1European society
1Female
1Final dose titration
1Follow-Up Studies
1General practitioners
1Guideline
1Heart Failure (blood)
1Heart Failure (drug therapy)
1Heart Failure (mortality)
1Heart failure
1Heart failure patients
1Heart rate
1Hospital admission
1Hospital admissions
1Hospitalization (statistics & numerical data)
1Humans
1Hyperkalaemia
1Hypotension
1Increase survival
1Inhibitor
1Insulin-Like Growth Factor Binding Proteins (blood)
1Isosorbide dinitrate
1Line treatment
1Male
1Mcmurray
1Metoprolol
1Morbidity
1Nsaid
1Nyha
1Nyha class
1Other vasodilators
1Patient education
1Practical guidance
1Practical recommendations
1Practice guidelines
1Primary care
1Prognosis
1Randomised
1Randomised trial
1Randomized
1Randomized trial
1Receptor
1Renal
1Renal dysfunction
1Renal function
1Renin angiotensin aldosterone system
1Risk Factors

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Robert S. Mckelvie" 
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Robert S. Mckelvie" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Robert S. Mckelvie
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024